Novopyxis Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Novopyxis General Information

Description

Developer of a transdermal delivery system designed to facilitate drug delivery for treatments. The company's system is painless, contact-free, portable, generates no disposables, and is used to treat neurological disorders, enabling doctors to effectively treat diseases by being able to inject drugs and facilitate the delivery of large molecules deep through the skin.

Contact Information

Website
www.novopyxis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (617)
Primary Industry
Drug Delivery
Other Industries
Decision/Risk Analysis
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • One Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novopyxis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Jan-2026 Completed Generating Revenue
7. Grant 28-May-2020 Completed Generating Revenue
6. Later Stage VC (Series A) 02-Aug-2019 Completed Generating Revenue
5. Grant 01-Jan-2018 Completed Generating Revenue
4. Early Stage VC 21-Jul-2017 Completed Generating Revenue
3. Grant 12-Apr-2015 Completed Generating Revenue
2. Accelerator/Incubator 22-Jul-2014 $1M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Novopyxis’s complete valuation and funding history, request access »

Novopyxis Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • 34

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Novopyxis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230135747-A1 Fluid delivery system Inactive 28-Oct-2021
WO-2023076412-A1 Fluid delivery system Inactive 28-Oct-2021
US-D1066684-S1 Applicator Active 30-Sep-2021
US-D1140063-S1 Applicator Active 30-Sep-2021
US-D1067459-S1 Capsule Active 30-Sep-2021
To view Novopyxis’s complete patent history, request access »

Novopyxis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novopyxis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Bantam Group Angel Group Minority
Spark Capital Venture Capital Minority
Zühlke Engineering Corporation Minority
Boeing Corporation Minority
To view Novopyxis’s complete investors history, request access »

Ready to get started?

Request a free trial

Novopyxis FAQs

  • When was Novopyxis founded?

    Novopyxis was founded in 2013.

  • Where is Novopyxis headquartered?

    Novopyxis is headquartered in Cambridge, MA.

  • What is the size of Novopyxis?

    Novopyxis has 4 total employees.

  • What industry is Novopyxis in?

    Novopyxis’s primary industry is Drug Delivery.

  • Is Novopyxis a private or public company?

    Novopyxis is a Private company.

  • What is Novopyxis’s current revenue?

    The current revenue for Novopyxis is .

  • How much funding has Novopyxis raised over time?

    Novopyxis has raised $9.3M.

  • Who are Novopyxis’s investors?

    National Institutes of Health, Bantam Group, Spark Capital, Zühlke Engineering, and Boeing have invested in Novopyxis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process